Bank Of America Corp Shattuck Labs, Inc. Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 50,986 shares of STTK stock, worth $60,163. This represents 0.0% of its overall portfolio holdings.

Number of Shares

50,986

Previous 53,299 4.34%

Holding current value

$60,163

Previous $476,000 58.82%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$3.56 - $11.18 $8,234 - $25,859	-2,313 Reduced 4.34%	50,986 $196,000
Q1 2024 May 15, 2024	BUY	$7.37 - $10.09 $46,099 - $63,112	6,255 Added 13.3%	53,299 $476,000
Q4 2023 Feb 14, 2024	BUY	$1.37 - $7.24 $260 - $1,375	190 Added 0.41%	47,044 $335,000
Q2 2023 Aug 14, 2023	SELL	$2.52 - $3.66 $2,315 - $3,363	-919 Reduced 1.92%	46,854 $146,000
Q1 2023 May 12, 2023	BUY	$2.5 - $4.72 $22,637 - $42,739	9,055 Added 23.39%	47,773 $140,000
Q4 2022 Feb 10, 2023	BUY	$1.96 - $3.26 $44,350 - $73,767	22,628 Added 140.63%	38,718 $89,000
Q3 2022 Nov 14, 2022	BUY	$2.6 - $5.52 $41,519 - $88,148	15,969 Added 13197.52%	16,090 $43,000
Q2 2022 Aug 12, 2022	SELL	$2.7 - $4.59 $22,266 - $37,853	-8,247 Reduced 98.55%	121 $0
Q1 2022 May 16, 2022	SELL	$4.22 - $8.89 $54,564 - $114,947	-12,930 Reduced 60.71%	8,368 $35,000
Q4 2021 Feb 08, 2022	BUY	$8.36 - $21.08 $21,368 - $53,880	2,556 Added 13.64%	21,298 $181,000
Q3 2021 Nov 15, 2021	BUY	$17.57 - $28.95 $156,056 - $257,133	8,882 Added 90.08%	18,742 $382,000
Q2 2021 Sep 13, 2021	BUY	$24.14 - $37.68 $238,020 - $371,524	9,860 New	9,860 $286,000

Others Institutions Holding STTK

# of Institutions

Shares Held

27M

Call Options Held

3.1K

Put Options Held

23.9K

View Full List

About Shattuck Labs, Inc.

Ticker STTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,382,000
Market Cap $50M
Description
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...

More about STTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Shattuck Labs, Inc. Transaction History